MetaCap

AN2 Therapeutics (ANTX) News

NASDAQ: ANTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.08-0.14 (-2.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ANTX news summary

We found 3 recent headlines mentioning AN2 Therapeutics (ANTX): 1 in the past week and 2 in the past 30 days, most often from Nasdaq, Business Wire, PR Newswire. For price context, ANTX is down 2.68% at $5.08. The most recent story, "Biotech Stocks On The Rise - AKAN +88%, CUE +49%, ADAG +24%, ANTX +23%, NRXP +10%", was published by Nasdaq on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest AN2 Therapeutics headlines

Stocks mentioned alongside ANTX

Compare ANTX